programmed cell death protein 1 blockadecervical cancerSquamous cell carcinomaadenocarcinomaThe Cancer Genome Atlas
…ervical cancer shows limited and often short-lived benefit from programmed cell death protein 1 blockade, currently the only approved immunotherapy for this disease. Th…